Radiosensitivity Enhancement by Arsenic Trioxide in Conjunction with Hyperthermia in the EC-1 Esophageal Carcinoma Cell Line

Objective: To explore the effect on radiosensitivity of arsenic trioxide (As(2)0(3)) in conjunction with hyperthermia on the esophageal carcinoma EC-1 cell line. Method: Inhibition of EC-1 cell proliferation at different concentrations of As(2)0(3) was assessed using the methyl thiazolyl blue colorimetric method (MTT method), with calculation of IC50 value and choice of 20% of the IC50 as the experimental drug concentration. Blank control, As(2)0(3,) hyperthermia, radiotherapy group, As(2)0(3) + hyperthermia, As(2)0(3) + radiotherapy, hyperthermia + radiotherapy and As(2)0(3) + hyperthermia + radiotherapy groups were established, and the cell survival fraction (SF) was calculated from flat panel colony forming analysis, and fitted by the 'multitarget click mathematical model'. Flow cytometry (FCM) was used to detect changes in cell apoptosis and the cell cycle. Results: As(2)0(3) exerted inhibitory effects on proliferation of esophageal carcinoma EC-1 cells, with an IC50 of 18.7 mu mol/L. After joint therapy of As(2)0(3) + hyperthermia + radiotherapy, the results of FCM showed that cells could be arrested in the G(2)/M phase, and as the ratio of cells in G(0)/G(1) and S phases decreased, cell death became more pronounced. Conclusion: As(2)0(3) and hyperthermia exert radiosensitivity effects on esophageal carcinoma EC-1 cells, with synergy in combination. Mechanistically, As(2)0(3) and hyperthermia mainly influence the cell cycle distribution of EC-1 esophageal carcinoma cells, decreasing the repair of sublethal damage and inducing apoptosis, thereby enhancing the killing effects of radioactive rays.